Evidence map›Paper›PMID 38453448›Full record

ReviewZhongguo fei ai za zhi = Chinese journal of lung cancer2024

[Intravascular Large B-cell Lymphoma Presenting with Lung Adenocarcinoma:
A Case Report and Literature Review].

Tongtong Wang, Xiaoyue Chen, Guochen Duan, Xiaopeng Zhang, Qingtao Zhao, Shun Xu, Huanfen Zhao

Abstract readReviewCase ReportsEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tongtong WangDepartment of Graduate School, Hebei Medical University, Shijiazhuang 050000, China.
Xiaoyue ChenDepartment of Pathology, Hebei General Hospital, Shijiazhuang 050000, China.
Guochen DuanDepartment of Thoracic Surgery, Hebei Children's Hospital, Shijiazhuang 050000, China.
Xiaopeng ZhangDepartment of Thoracic Surgery, Hebei General Hospital, Shijiazhuang 050000, China.
Qingtao ZhaoDepartment of Thoracic Surgery, Hebei General Hospital, Shijiazhuang 050000, China.
Shun XuDepartment of Thoracic Surgery, The First Hospital of China Medical University, Shenyang 110001, China.
Huanfen ZhaoDepartment of Pathology, Hebei General Hospital, Shijiazhuang 050000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intravascular large B-cell lymphoma (IVLBCL) is an aggressive extranodal large B-cell lymphoma, cocurrence in the same organ with other malignancies is very rare, especially in the lung. Here, we report a rare case of lung adenocarcinoma with IVLBCL. The patient was admitted to the hospital due to diarrhea associated with fever and cough. A computed tomography (CT) scan of the chest showed an irregular patchy high-density shadow in the upper lobe of the right lung with ground-glass opacity at the margin. After admission, the patient was given anti-infection treatment, but still had intermittent low fever (up to 37.5 °C). The pathological diagnosis of percutaneous lung biopsy (PLB) was lepidic-predominant adenocarcinoma with local infiltration, which was proved to be invasive nonmucinous adenocarcinoma of the lung with IVLBCL after surgery. This paper analyzed the clinicopathological characteristics and reviewed the relevant literature to improve the knowledge of clinicians and pathologists and avoid missed diagnosis or misdiagnosis.
.

Indexed as

AdenocarcinomaAdenocarcinoma of LungLung NeoplasmsLymphoma, Large B-Cell, DiffuseHumansLungIntravascular large B-cell lymphomaLung adenocarcinomaLung neoplasms

Identifiers

PMID38453448
PMCPMC10918342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.